202850-01-9
N-[12-[(7-Nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-ceramide
C12-NBD Ceramide
N-[(E,2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]-12-[(4-nitro-2,1,3-benzoxadiazol-7-yl)amino]dodecanamide
CHEBI:143826 CAS 202850-01-9
Purity 97%+In StockPharmaceutical Standards
CAS No.
202850-01-9
Molecular Formula
C36H61N5O6
Molecular Weight
659.90 g/mol
Category
Pharmaceutical Standards / API Standards
Availability
In Stock
Chemical Structure
Description
202850-01-9
N-[12-[(7-Nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-ceramide
C12-NBD Ceramide
N-[(E,2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]-12-[(4-nitro-2,1,3-benzoxadiazol-7-yl)amino]dodecanamide
CHEBI:143826 (CAS 202850-01-9) is a high-purity pharmaceutical standards reference standard from CATO, an ISO 17034 accredited reference material producer. Molecular formula: C36H61N5O6. Molecular weight: 659.90 g/mol. Each batch is supplied with a Certificate of Analysis (COA).
Physical & Chemical Properties
Molecular Formula
C36H61N5O6
Molecular Weight
659.90 g/mol
Purity
97%+
Storage
Store in a cool place (≤25°C), protect from light, keep sealed and dry
Solubility (reference)
Soluble in DMSO, DMF, methanol
Stability
May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening